Search - tctmd.com

Displaying 561 - 580 of 1003

Sort: Relevancy | Date

Presentation TCT 2016

In This Case: Contrast Was an Alternative to Adenosine for Stenosis Interrogation

Presenter: Javier Escaned, Habib Samady, William F. Fearon

October 30, 2016

Presentation TCT 2016

Case Presentations: Intravascular Imaging and Physiologic Assessment Should Be Mandatory When Treating Calcified Lesions

Presenter: Mohamed Abdel-Wahab, Philippe Généreux, Ziad A. Ali

October 30, 2016

Presentation TCT 2016

In This Case: iFR Vessel Mapping Was Key to Identify the PCI Target Segment

Presenter: Javier Escaned, Habib Samady, Hitoshi Matsuo

October 30, 2016

Presentation TCT 2016

In This Case: FFR in Complex Multivessel PCI Was Key for Decision-making

Presenter: Javier Escaned, Habib Samady, Keith G. Oldroyd

October 30, 2016

Presentation TCT 2016

Coronary Pathophysiology and FFR

Presenter: Peter Barlis, Grzegorz L. Kaluza, Allen Jeremias

October 29, 2016

Presentation Stanford Coronary Physiology Conference 2016

ABSOLUTE FLOW: Concepts And Practical Aspects

Presenter: Nico H. J. Pijls

October 28, 2016

Presentation Stanford Coronary Physiology Conference 2016

New Pressure Wires and Catheters Systems for Measuring FFR

Presenter: Morton J. Kern

October 28, 2016

Presentation Stanford Coronary Physiology Conference 2016

Adenosine-free Indices: Resting Pd/Pa, iFR, and cFFR

Presenter: Nils P. Johnson

October 28, 2016

Presentation Stanford Coronary Physiology Conference 2016

Real World FFR Experience

Presenter: Jung-Min Ahn

October 28, 2016

Presentation Stanford Coronary Physiology Conference 2016

Will FFR-Directed PCI Be Better Than CABG? Update on the FAME 3 trial

Presenter: William F. Fearon

October 28, 2016

Presentation Stanford Coronary Physiology Conference 2016

FFR-Guided PCI Vs Medical Therapy: FAME 2 and Substudies

Presenter: Bernard De Bruyne

October 28, 2016

Presentation Stanford Coronary Physiology Conference 2016

FFR After Stenting. Is There a Role?

Presenter: Nico H. J. Pijls

October 28, 2016

Presentation Stanford Coronary Physiology Conference 2016

Assessing Chest Pain and Non-obstructive CAD

Presenter: Jennifer A. Tremmel

October 28, 2016

Presentation Stanford Coronary Physiology Conference 2016

FFR in Left Main Disease

Presenter: William F. Fearon

October 28, 2016

Presentation Stanford Coronary Physiology Conference 2016

FFR In Acute Coronary Syndromes

Presenter: Colin Berry

October 28, 2016

Presentation

FFR in Left Main Disease

Presenter: William F. Fearon

October 28, 2016

Presentation Stanford Coronary Physiology Conference 2016

Index of Microcirculatory Resistance: Derivation, Validation and Practical Aspects

Presenter: William F. Fearon

October 28, 2016

Presentation Stanford Coronary Physiology Conference 2016

How to Assess Serial Lesions

Presenter: Habib Samady

October 28, 2016

Presentation Stanford Coronary Physiology Conference 2016

FFR in... Bifucation Disease

Presenter: Nils P. Johnson

October 28, 2016

Presentation Stanford Coronary Physiology Conference 2016

FFR in Multivessel Disease: FAME-1 and Substudies

Presenter: Nico H. J. Pijls

October 28, 2016

Advertisement

In This Case: Contrast Was an Alternative to Adenosine for Stenosis Interrogation

Case Presentations: Intravascular Imaging and Physiologic Assessment Should Be Mandatory When Treating Calcified Lesions

In This Case: iFR Vessel Mapping Was Key to Identify the PCI Target Segment

In This Case: FFR in Complex Multivessel PCI Was Key for Decision-making

Coronary Pathophysiology and FFR

ABSOLUTE FLOW: Concepts And Practical Aspects

New Pressure Wires and Catheters Systems for Measuring FFR

Adenosine-free Indices: Resting Pd/Pa, iFR, and cFFR

Real World FFR Experience

Will FFR-Directed PCI Be Better Than CABG? Update on the FAME 3 trial

FFR-Guided PCI Vs Medical Therapy: FAME 2 and Substudies

FFR After Stenting. Is There a Role?

Assessing Chest Pain and Non-obstructive CAD

FFR in Left Main Disease

FFR In Acute Coronary Syndromes

FFR in Left Main Disease

Index of Microcirculatory Resistance: Derivation, Validation and Practical Aspects

How to Assess Serial Lesions

FFR in... Bifucation Disease

FFR in Multivessel Disease: FAME-1 and Substudies

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content